You're in the right place! Welcome to our newly updated ESC website.
Start exploring or use our powerful new search engine to find what you need.

Consensus and Position Papers on Cardiovascular Pharmacotherapy

ESC Working Group on Cardiovascular Pharmacotherapy

2024

Update on antithrombotic therapy and body mass. A Clinical consensus Statement of the ESC Working Group on Cardiovascular Pharma
2024

Management of cardiac emergencies in women
2023

Acute LDL-C reduction post ACS: strike early and strike strong: from evidence to clinical practice. A clinical consensus statement of the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Association of Preventive Cardiology (EAPC) and the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
2022

Sex differences in arterial hypertension
2022

Sex differences in arterial hypertension: A scientific statement from the ESC Council on Hypertension, the European Association of Preventive Cardiology, Association of Cardiovascular Nursing and Allied Professions, the ESC Council for Cardiology Practice, and the ESC Working Group on Cardiovascular Pharmacotherapy
2022

Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease. A review by the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
2021
Challenges in Cardiovascular Pharmacogenomics Implementation: A viewpoint from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
2021

Antithrombotic therapies in aortic and peripheral arterial diseases in 2021: a consensus document from the ESC working group on aorta and peripheral vascular diseases, the ESC working group on thrombosis, and the ESC working group on cardiovascular pharmacotherapy
2021

Update on management of hypokalaemia and goals for the lower potassium level in patients with cardiovascular disease: a review in collaboration with the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
2021

The Role of Pharmacogenomics in Contemporary Cardiovascular Therapy: A position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
2020

Peripartum management of hypertension: a position paper of the ESC Council on Hypertension and the European Society of Hypertension Renata Cífková, Mark R Johnson, Thomas Kahan, Jana Brguljan, Bryan Williams ... European Heart Journal - Cardiovascular Pharmacotherapy, Volume 6, Issue 6, November 2020, Pages 384–393
2020

An expert opinion paper on statin adherence and implementation of new lipid-lowering medications by the ESC Working Group on Cardiovascular Pharmacotherapy: Barriers to be overcome
2019

Lipid management in rheumatoid arthritis: a position paper by the Cardiovascular Pharmacotherapy Working Group of European Society of Cardiology.
2018

Management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors
2018

Antiarrhythmic drugs–clinical use and clinical decision making
2017

Non-insulin antidiabetic pharmacotherapy in patients with established cardiovascular disease: a position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
2016

Myocardial infarction with non-obstructive coronary arteries
2016
Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs
2015

Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management
2015

Gender differences in the effect of cardiovascular drugs
2013

Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy
2013

The use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy